Dave is a Managing Partner at Health Enterprise Partners, a healthcare IT and services-focused growth equity firm. Among the key distinguishing features of HEP is a strategic investor base comprising 30+ hospital systems and healthcare insurance companies. Equipped with insights from its industry limited partners, HEP seeks to invest in companies that map to the most pressing executive priorities of the top healthcare organizations.
Prior to joining HEP in 2009, Dave was a Vice President of Susquehanna Growth Equity, a private equity group focused on growth capital opportunities in the technology sector. From 2002 to 2007, he was the President and Chief Operating Officer of Onward Healthcare, Inc., a Welsh, Carson, Anderson & Stowe portfolio company that provides human capital services to health care providers. Prior to Onward, from 1999 to 2002, Dave was an Executive Vice President of Pinnacor, Inc., a provider of information and analytical applications where he managed the company’s worldwide operations.
He is currently on the board of directors of Bardy Diagnostics, Catapult Health, eVariant, Jet Health, and Shyft Analytics. Dave previously served on the board of directors for HealthQx (acquired by McKesson), MobileMD (acquired by Siemens Healthcare), Nordic Consulting (recapitalized by Silversmith Capital Partners), Privia Health (merged with Brighton Health), and Vitals. He is on the faculty of Columbia Business School and the School of Professional Studies at Columbia University.
Dave is a distinguished graduate of the United States Military Academy and holds an MBA from Harvard Business School.